N. Voloshyná

How Does Fingolimod (Gilenya®) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?

F. Fazekas, E. Havrdová, L. Traykov, 2013, Front. Neurol..

MATRIX METALLOPROTEINASE-9 AND INFLAMMATION IN DIFFERENT TYPES OF MULTIPLE SCLEROSIS

V. Vovk, M.Ye. Chernenko, N. Voloshyná, 2016 .

Natalizumab improves ambulation in relapsing−remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM

M. Hutchinson, E. Havrdová, C. Hotermans, 2014, European journal of neurology.